Amino-acid substrates in new bottles: Implications for clinical nutrition in the 21st century

Nutrition

Volumn 16, Issue 7-8, 2000, Pages 603-606

  Fürst, Peter ^a   Kuhn, Katharina S ^a  

^a UNIVERSITY OF HOHENHEIM   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYSTEINE; DIPEPTIDE; TAURINE; TYROSINE;

CONFERENCE PAPER; CRITICAL ILLNESS; HUMAN; IMMUNITY; NUTRITION; NUTRITIONAL HEALTH; PRIORITY JOURNAL; WOUND HEALING;

AMINO ACIDS; ARGININE; CYSTEINE; DIPEPTIDES; DRUG PACKAGING; DRUG STABILITY; HUMANS; NUTRITIONAL SUPPORT; TAURINE; TYROSINE;

EID: 0034235474     PISSN: 08999007     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0899-9007(00)00321-X     Document Type: Conference Paper

References (30)

1. Fürst P., Stehle P. Are intravenous amino acid solutions unbalanced? New Horiz. 2:1994;215.
2. Fürst P. Old and new substrates in clinical nutrition. J Nutr. 128:1998;789.
3. Hardy G. Nutraceuticals and functional foods introduction and meaning . Nutrition. 2000;16.
4. Wilmore D.W. Catabolic Illness. Strategies for enhancing recovery. N Engl J Med. 325:1991;695.
5. Rudman D., Rajender C.K., Bleier J.C. Cystine and tyrosine requirements during the nutritional depletion of cirrhotic patients. Blackburn G.L., Grant J.P., Young V.R. Amino acids. Metabolism and medical applications. 1983;484 John Wright, London.
6. Young G.A., Parsons F.M. Impairment of phenylalanine hydroxylation in chronic renal insufficiency. Clin Sci Mol Med. 45:1973;89.
7. Sturman J.A., Gaull G., Räihä N.C.R. Absence of cystathionase in human fetal liver. Is cystine essential? Science. 169:1970;74.
8. Räihä N.C.R. Phenylalanine hydroxylase in human liver during development. Pediatr Res. 7:1973;1.
9. Young V.E., El-Khoury A.E. The notion of the nutritional essentiality of amino acids, revisited, with a note on the indispensable amino acid requirements in adults. Cynober L. Amino acid metabolism and therapy in health and nutritional disease. 1st ed. 1995;191 CRC Press, Boca Raton.
10. Huxtable R.J. Physiological actions of taurine. Physiol Rev. 72:1992;101.
11. Grimble R.F., Grimble G.K. Immunonutrition role of sulfur amino acids, related amino acids, and polyamines . Nutrition. 14:1998;605.
12. Najarian N., Harper A.E. A clinical study of the effect of arginine on blood ammonia. Am J Med. 21:1956;832.
13. Daly J.M., Reynolds J., Thom A. Immune and metabolic effects of arginine in the surgical patient. Ann Surg. 208:1988;512.
14. Barbul A. Arginine and immune function. Nutrition. 6:1990;53.
15. Yu J.C., Jiang Z.M., Li D.M., Yang N.F., Bai M.X. Alanyl-glutamine preserves hepatic glutathione stores after 5-FU treatment. Clin Nutr. 15:1996;261.
16. Hong R.W., Rounds J.D., Helton W.S., Robinson M.K., Wilmore D.W. Glutamine preserves liver glutathione after lethal hepatic injury. Ann Surg. 215:1992;114.
17. Morlion B.J., Köller M., Wachtler P., et al. Influence of L-alanyl-L-glutamine (ala-gln) dipeptide on the synthesis of leukotrienes and cytokines in vitro. 4th International Congress on the immune consequences of trauma, shock and sepsis. 1997;269 Monduzzi Editore, Bologna, Italy.
18. deBeaux A.C., O'Riordain M.G., Ross J.A., et al. Glutamine-supplemented total parenteral nutrition reduces blood mononuclear cell interleukin-8 release in severe acute pancreatitis. Nutrition. 14:1998;261.
19. Morlion B.J., Torwesten E., Kuhn K.S., et al. Cysteinyl-leucotriene generation as a biomarker for survival in the critically ill. Crit Care Med. 2000;. (in press).
20. Lacey J.M., Crouch J.B., Benfell K., et al. The effects of glutamine-supplemented parenteral nutrition in premature infants. JPEN. 20:1996;74.
21. Häussinger D., Roth E., Lang F., Gerok W. Cellular hydration state an important determinant of protein catabolism in health and disease . Lancet. 341:1993;1330.
22. Ballard T.C., Farag A., Branum G.D., Akwardi O.E., Opara E.C. Effect of L-glutamine supplementation on impaired glucose regulation during intravenous lipid administration. Nutrition. 12:1996;349.
23. Khogali S.E., Harper A.A., Lyall J.A., Rennie M.J. Effects of L-glutamine on post-ischaemic cardiac function protection and rescue . J Mol Cell Cardiol. 30:1998;819.
24. Fish J., Sporay G., Beyer K., et al. A prospective randomized study of glutamine-enriched parenteral compared with enteral feeding in postoperative patients. Am J Clin Nutr. 65:1997;977.
25. Bauer P., Charpentier C., Bouchet C., et al. Short parenteral nutrition coupled with early enteral nutrition in the critically ill. Intens Care Med. 24:1998;S123.
26. Druml W. Nutritional considerations in the treatment of acute renal failure in septic patients. Nephrol Dialysis Transplant. 9:1994;S219.
27. Druml W., Hübl W., Roth E., Lochs H. Utilization of tyrosine-containing dipeptides and N-acetyl-tyrosine in hepatic failure. Hepatology. 21:1995;923.
28. Dröge W. Cysteine and glutathione deficiency in AIDS patients a rationale for the treatment with N-acetly-cysteine . Pharmacology. 46:1993;61.
29. Fürst P., Pogan K., Hummel M., Herzog B., Stehle P. Design of parenteral synthetic dipeptides for clinical nutrition in vitro and in vivo utilization . Ann Nutr Metab. 41:1997;10.
30. Cynober L. Can arginine and ornithine support gut functions? Gut. 35:1994;S42.